Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “the Haploidentical Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableLooking for participantsNCT06512545
What this trial is testing

Modified Second Haplo-transplantation for Graft Failure

Who this might be right for
Graft FailureStem Cell Transplant Complications
Peking University People's Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT01861106
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

Who this might be right for
GATA2ImmunodeficiencyMDS
National Cancer Institute (NCI) 144
Early research (Phase 1)Ended earlyNCT00586274
What this trial is testing

Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT

Who this might be right for
FANCONI ANEMIA
Baylor College of Medicine 1
Testing effectiveness (Phase 2)Enrolling By InvitationNCT02646839
What this trial is testing

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes
Michael Pulsipher 50
Early research (Phase 1)Active Not RecruitingNCT03249831
What this trial is testing

A Blood Stem Cell Transplant for Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell DisorderHemoglobinopathies+2 more
City of Hope Medical Center 3
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Not applicableStudy completedNCT01071226
What this trial is testing

Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device

Who this might be right for
Malignant Diseases (ie, Leukemia, MDS, Lymphoma)Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
Medical College of Wisconsin 60
Testing effectiveness (Phase 2)WithdrawnNCT03438344
What this trial is testing

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+9 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01028716
What this trial is testing

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Biphenotypic LeukemiaAcute Erythroid Leukemia in RemissionAcute Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 46
Post-approval studies (Phase 4)UnknownNCT05914675
What this trial is testing

Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT

Who this might be right for
The Incidence of Peripheral Blood CMV Activation and Confirmed Clinically Significant CMV Infection Within 24 Weeks After Transplantation
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)Study completedNCT04503616
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

Who this might be right for
Graft-versus-host Disease
NYU Langone Health 46
Not applicableLooking for participantsNCT07499284
What this trial is testing

A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

Who this might be right for
Aplastic Anaemia
The First Affiliated Hospital of Soochow University 224
Not applicableStudy completedNCT01997918
What this trial is testing

Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT

Who this might be right for
Relapse of Hematological Malignancies
University Hospital Tuebingen 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04060277
What this trial is testing

Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center 7